The session, titled "Applications of Optical Coherence Tomography (OCT)," will review OCT technology, and its applications in diagnosis, guided surgery, and follow up. The session will be held Friday August 18th at 6:00 a.m. in the Six Continents Room of the Intercontinental Hotel and Conference Center, Cleveland, Ohio.
The session will be chaired by Dr. Michael J. Manyak, of George Washington University Medical Center, Walter Reed Army Medical Center, and Cytogen Corporation. Additional presentations will be provided by Dr. Jihad Kaouk, Co Director, Robotic Urologic Surgery, Cleveland Clinic Foundation, and Dr. Nancy Tresser, Vice President and Medical Director Imalux Corporation.
Imalux will also exhibit at the Conference and take part in two abstract poster presentations on OCT. The Niris Imaging System will also be utilized hands-on in the pre-conference laparoscopic prostatectomy workshops.
Imalux developed, manufacturers and markets the Niris Imaging System to assist physicians in their diagnosis, treatment, and therapeutic monitoring of disease in urology, gastroenterology, gynecology, dermatology, dentistry, and ENT applications.
"We are very proud to hold our initial post graduate session on OCT. The World Congress of Endourology is a very appropriate venue for this conference, and we are optimistic that the attendees will find the session, as well as the abstracts and workshops very beneficial and informative," states Jerry C. Cirino, President and Chief Executive Officer of Imalux.
About Imalux & the Niris Imaging System
Imalux Corporation, based in Cleveland, Ohio, is commercializing Optical Coherence Tomography ("OCT") technology originally developed at the Institute of Applied Physics of the Russian Academy of Sciences, one of the main progenitors of OCT technology worldwide. The application of the proven OCT technology is on the verge of becoming the sixth major imaging modality.
The Company's Niris™ Imaging System is a compact, point-of-care System that creates images utilizing harmless, near infrared light. Niris provides clinicians with real-time, high spatial resolution, two-dimensional, cross-sectional depth visualization of normal and abnormal tissue microstructures The spatial resolution of the System is on the order of 0.01 mm, surpassing conventional ultrasound imaging by an order of magnitude. Imalux OCT technology has been under evaluation with physicians in a number of specialty areas and has been used with more than 3,000 patients worldwide at leading medical institutions including The Cleveland Clinic, The George Washington University Medical Center, Baylor College of Medicine/The Methodist Hospital, University Hospitals of Cleveland, Nizhny Novgorod Medical Academy and Regional Hospital, Nizhny Novgorod, Russia; Municipal Hospital, Chartres, France; State Hospital, Athens, Greece; University Clinic of Eppendorf, Hamburg, Germany; and Hospital Maternidad Nuestra Senora de la Altagracia, Santo Domingo, Dominican Republic.
The Niris Imaging System has received market clearance from the U.S. Food & Drug Administration. In addition, Imalux has received ISO 13485:2003 certification and been awarded the CE Mark for the Niris Imaging System.
Contact information:
Imalux Corporation
Jon J. Snyder
Vice President, Marketing and Sales
Phone: 216-502-0755, ext. 312
web: www.imalux.com